These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 33573666

  • 21. Hyperglycemia on admission and hospitalization outcomes in patients with atrial fibrillation.
    Akirov A, Grossman A, Shochat T, Shimon I.
    Clin Cardiol; 2017 Nov; 40(11):1123-1128. PubMed ID: 28898432
    [Abstract] [Full Text] [Related]

  • 22. Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes.
    Blecker S, Park H, Katz SD.
    BMC Cardiovasc Disord; 2016 May 20; 16():99. PubMed ID: 27206478
    [Abstract] [Full Text] [Related]

  • 23. Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population-Based Cohort Study.
    Abdel-Qadir H, Gunn M, Lega IC, Pang A, Austin PC, Singh SM, Jackevicius CA, Tu K, Dorian P, Lee DS, Ko DT.
    J Am Heart Assoc; 2022 Feb 15; 11(4):e023643. PubMed ID: 35132863
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial.
    Proietti M, Raparelli V, Olshansky B, Lip GY.
    Clin Res Cardiol; 2016 May 15; 105(5):412-20. PubMed ID: 26525391
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study.
    Lee YB, Han K, Kim B, Lee SE, Jun JE, Ahn J, Kim G, Jin SM, Kim JH.
    Cardiovasc Diabetol; 2019 Nov 16; 18(1):157. PubMed ID: 31733656
    [Abstract] [Full Text] [Related]

  • 28. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.
    Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M, PARADIGM-HF Investigators and Committees.
    Circ Heart Fail; 2016 Jan 16; 9(1):. PubMed ID: 26754626
    [Abstract] [Full Text] [Related]

  • 29. Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study.
    Dong Z, Du X, Lu S, Jiang C, Xia S, He L, Su X, Jia Z, Long D, Sang C, Tang R, Liu N, Bai R, Yu R, Dong J, Ma C.
    BMC Cardiovasc Disord; 2021 Mar 19; 21(1):146. PubMed ID: 33740910
    [Abstract] [Full Text] [Related]

  • 30. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).
    Fatemi O, Yuriditsky E, Tsioufis C, Tsachris D, Morgan T, Basile J, Bigger T, Cushman W, Goff D, Soliman EZ, Thomas A, Papademetriou V.
    Am J Cardiol; 2014 Oct 15; 114(8):1217-22. PubMed ID: 25159234
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.
    Papazoglou AS, Kartas A, Moysidis DV, Tsagkaris C, Papadakos SP, Bekiaridou A, Samaras A, Karagiannidis E, Papadakis M, Giannakoulas G.
    Cardiovasc Diabetol; 2022 Mar 14; 21(1):39. PubMed ID: 35287684
    [Abstract] [Full Text] [Related]

  • 33. Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults.
    Bajaj NS, Bhatia V, Sanam K, Ather S, Hashim T, Morgan C, Fonarow GC, Nanda NC, Prabhu SD, Adamopoulos C, Kheirbek R, Aronow WS, Fletcher RD, Anker SD, Ahmed A, Deedwania P.
    Am J Cardiol; 2014 Sep 15; 114(6):909-13. PubMed ID: 25208562
    [Abstract] [Full Text] [Related]

  • 34. The impact of hemoglobin A1c on outcomes after lower extremity bypass.
    Lee A, Haddad D, Rybin D, Howell C, Ghaderi I, Berman S, Zhou W, Tan TW.
    J Vasc Surg; 2021 Apr 15; 73(4):1332-1339.e5. PubMed ID: 32730894
    [Abstract] [Full Text] [Related]

  • 35. Risk of Atrial Fibrillation in Relation to the Time Course of Type 2 Diabetes Mellitus and Fasting Blood Glucose.
    Yang S, Choi EK, Han KD, Kwon S, Lee SY, Park J, Choi YJ, Lee HJ, Moon I, Lee E, Lee SR, Cha MJ, Lim WH, Oh S.
    Am J Cardiol; 2019 Dec 15; 124(12):1881-1888. PubMed ID: 31668346
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Relation of Diabetes Mellitus to Incident Dementia in Patients With Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study).
    Jiayaspathi A, Chen LY, Selvin E, Gottesman RF, Knopman DS, Mosley TH, Norby FL, Alonso A.
    Am J Cardiol; 2022 Feb 15; 165():51-57. PubMed ID: 34887073
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry.
    Domek M, Gumprecht J, Li YG, Proietti M, Rashed W, Al Qudaimi A, Gumprecht J, Zubaid M, Lip GYH.
    Eur J Clin Invest; 2021 Mar 15; 51(3):e13385. PubMed ID: 32810282
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.